The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide laboratory testing supplies and equipment. The IDV has a potential value of $6.5 million and period of performance through June 2027. Three delivery orders have been issued against the contract to date for a total of $246,135.04, $231,704.12, and $13,824 for reagents, supplies, and molecular testing systems respectively. Places of performance include medical centers in Castleton, Indiana, Honolulu, Hawaii, and unspecified locations within VISN 21.
The original pre-solicitation notice indicated intent to sole source award for SARS-CoV-2 testing supplies to Roche, as they are the sole manufacturer and distributor of Cobas SARS-CoV-2 test kits and controls authorized for emergency use on existing Cobas 6800 Systems. The diagnostic products will support molecular pathology services and COVID-19 screening/monitoring efforts for veterans within the VA Pacific Islands Health Care System and VISN 21 region. No set-asides were applied under the IDV or associated orders. The laboratory equipment, reagents, and supplies provided by Roche under the contract aim to maintain the VA's diagnostic testing capabilities.
Generated 1/5/24, 2:12 AM